Live Quote · OTCHYPMYHealthcare · Drug Manufacturers - Specialty & Generic

Hypera S.A.

$4.17▲ 1.81%(+$0.07)

TickerSpark Score

63/100

▌ Mixed

100

Valuation

85

Profitability

25

Growth

76

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYPMY research report →

52-Week Range26% of range

Low

$3.71

Current

$4.17

High

$5.50

Company Overviewwww.hyperapharma.com.br

About the company

Hypera S. A. is a prominent pharmaceutical enterprise primarily operating within Brazil.

CEO: Breno Toledo Pires de Oliveira
IPO: 2010
Employees: 10,481
HQ: São Paulo, SP, BR

Price Chart

-16.93% · this period

Valuation

Market Cap: $2.93B
P/E: 7.89
P/S: 1.71
P/B: 0.94
EV/EBITDA: 7.71
Div Yield: 5.26%

Profitability

Gross Margin: 58.96%
Op Margin: 28.54%
Net Margin: 19.48%
ROE: 13.23%
ROIC: 9.21%

Growth & Income

Revenue: $7.70B · 3.45%
Net Income: $1.20B · -10.86%
EPS: $1.89 · -10.85%
Op Income: $1.74B
FCF YoY: 0.44%

Performance & Tape

52W High: $5.50
52W Low: $3.71
50D MA: $4.37
200D MA: $4.42
Beta: 0.09
Avg Volume: 27.65K

Get TickerSpark's AI analysis on HYPMY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · HYPMY